Evotec AG (EVTG.DE)
23 May 2018
* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:
* SAYS PLANS CONVERSION INTO EUROPEAN COMPANY Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)
PARIS Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.
* SAYS EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI
* SAYS EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM